Nuvation Bio Inc. (NUVB) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.06B |
| Enterprise Value | 2.91B |
| P/E Ratio | -14.91 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 15.36 |
| Price/Book Ratio | 6.88 |
| Enterprise/Revenue | 14.56 |
| Enterprise/EBITDA | -16.05 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.02 |
| Operating Margin | -1.05 |
AD
Management Effectiveness
| Return On Assets | -0.24 |
| Return On Equity | -0.44 |
Income Statement
| Revenue | 62.9M |
| Revenue/Share | 0.41 |
| Gross Profit | 54.46M |
| EBITDA | -189.21M |
| Net Income | -204.63M |
| Diluted EPS | -0.6 |
Balance Sheet
| Total Cash | 533.73M |
| Total Cash/Share | 1.54 |
| Total Debt | 9.83M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 7.44 |
| Book Value Per Share | 0.92 |
Price History
| 52-Week Change | 174.03 |
| 52-Week High | 9.75 |
| 52-Week Low | 2.18 |
| Moving Average 50 Days | 5.56 |
| Moving Average 200 Days | 5.7 |
Statistics
| Average Volume | 6.52M |
| Shares Outstanding | 347.2M |
| % Held by Institutions | 63.49 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
